Icahn School Of Medicine At Mount Sinai

Salvage therapies appeared to maintain clinical activity among patients with relapsed/refractory multiple myeloma who relapsed after B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy, according to study results.

Carl H. June, MD, will receive the inaugural Maria I. New International Prize for Biomedical Research.

The FDA granted accelerated approval to teclistamab-cqyv for treatment of certain patients of myeloma.

For adults who undergo PCI with a drug-eluting stent, recommendations for dual antiplatelet therapy have evolved from a standard 1-year duration for most patients to a more nuanced approach that balances risks for ischemia and bleeding.

Lung disease that patients with cancer experience from the antibody-drug conjugate fam-trastuzumab deruxtecan-nxki can be treated effectively if detected early and managed promptly, according to study results published in ESMO Open.

Nina Bhardwaj, MD, PhD, has spent her career investigating dendritic cells and identifying novel cancer-specific antigens with the goal of developing an off-the-shelf vaccine for treatment, work that has recently garnered recognition.

Published results showed an increase in out-of-pocket expenses for patients undergoing arthroscopic ACL reconstruction despite a decrease in overall payer reimbursement.

During the past 2 decades, Endocrine Today has reported on the latest developments in testosterone therapy, including new formulations, debates over indications, and trials assessing risks and benefits for older men.

The advent of novel therapies has propelled, and continues to propel, tremendous progress and innovation in diffuse large B-cell lymphoma.

Women with polycystic ovary syndrome have worse diet quality and engage in less physical activity than women without PCOS, according to findings from a systematic review and meta-analysis.